Evidence map›Paper›PMID 34332019›Full record

ArticleThe Journal of infection2021

Epidemiological data and genome sequencing reveals that nosocomial transmission of SARS-CoV-2 is underestimated and mostly mediated by a small number of highly infectious individuals.

Sheila F Lumley, Bede Constantinides, Nicholas Sanderson, Gillian Rodger, Teresa L Street, Jeremy Swann, Kevin K Chau, Denise O'Donnell, Fiona Warren, Sarah Hoosdally and 11 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of infection, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
4.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 69 citations in OpenAlex.

  1. Min-frame transformation enables more sensitive viral genome alignment.bioRxiv : the preprint server for biology · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Observational
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. In Support of Universal Admission Testing for SARS-CoV-2 During Significant Community Transmission.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2024
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

21 authors at 3 institutions in 2 countries.

Sheila F LumleyJohn Radcliffe Hospital, Oxford University Hospitals NHS Foundation Trust etc.; Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom; NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, United Kingdom; NIHR Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance at University of Oxford in partnership with Public Health England, Oxford, United Kingdom. Electronic address: sheila.lumley@trinity.ox.ac.uk.
Bede ConstantinidesNuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.
Nicholas SandersonNuffield Department of Medicine, University of Oxford, Oxford, United Kingdom; NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, United Kingdom.
Gillian RodgerNuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.
Teresa L StreetNuffield Department of Medicine, University of Oxford, Oxford, United Kingdom; NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, United Kingdom.
Jeremy SwannNuffield Department of Medicine, University of Oxford, Oxford, United Kingdom; NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, United Kingdom.
Kevin K ChauNuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.
Denise O'DonnellNuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.
Fiona WarrenJohn Radcliffe Hospital, Oxford University Hospitals NHS Foundation Trust etc.
Sarah HoosdallyNuffield Department of Medicine, University of Oxford, Oxford, United Kingdom; NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, United Kingdom; NIHR Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance at University of Oxford in partnership with Public Health England, Oxford, United Kingdom.
OUH Microbiology laboratoryJohn Radcliffe Hospital, Oxford University Hospitals NHS Foundation Trust etc.
OUH Infection Prevention and Control teamJohn Radcliffe Hospital, Oxford University Hospitals NHS Foundation Trust etc.
Anne-Marie O'DonnellJohn Radcliffe Hospital, Oxford University Hospitals NHS Foundation Trust etc.; Nuffield Department of Population Health, University of Oxford, Oxford, Unit ed Kingdom.
Timothy M WalkerNuffield Department of Medicine, University of Oxford, Oxford, United Kingdom; Oxford University Clinical Research Unit, Ho Chi Minh City, Vietnam.
Nicole E StoesserJohn Radcliffe Hospital, Oxford University Hospitals NHS Foundation Trust etc.; Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom; NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, United Kingdom; NIHR Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance at University of Oxford in partnership with Public Health England, Oxford, United Kingdom.
Lisa ButcherJohn Radcliffe Hospital, Oxford University Hospitals NHS Foundation Trust etc.
Tim Ea PetoNuffield Department of Medicine, University of Oxford, Oxford, United Kingdom; NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, United Kingdom; NIHR Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance at University of Oxford in partnership with Public Health England, Oxford, United Kingdom.
Derrick W CrookNuffield Department of Medicine, University of Oxford, Oxford, United Kingdom; NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, United Kingdom; NIHR Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance at University of Oxford in partnership with Public Health England, Oxford, United Kingdom.
Katie JefferyJohn Radcliffe Hospital, Oxford University Hospitals NHS Foundation Trust etc.
Philippa C MatthewsJohn Radcliffe Hospital, Oxford University Hospitals NHS Foundation Trust etc.; Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom; NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, United Kingdom; NIHR Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance at University of Oxford in partnership with Public Health England, Oxford, United Kingdom.
David W EyreNIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, United Kingdom; NIHR Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance at University of Oxford in partnership with Public Health England, Oxford, United Kingdom; Nuffield Department of Population Health, University of Oxford, Oxford, Unit ed Kingdom; Big Data Institute, University of Oxford, Oxford, United Kingdom.
University of Oxford · GBOxford BioMedica (United Kingdom) · GBPublic Health England · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesDespite robust efforts, patients and staff acquire SARS-CoV-2 infection in hospitals. We investigated whether whole-genome sequencing enhanced the epidemiological investigation of healthcare-associated SARS-CoV-2 acquisition.

methodsFrom 17-November-2020 to 5-January-2021, 803 inpatients and 329 staff were diagnosed with SARS-CoV-2 infection at four Oxfordshire hospitals. We classified cases using epidemiological definitions, looked for a potential source for each nosocomial infection, and evaluated genomic evidence supporting transmission.

resultsUsing national epidemiological definitions, 109/803(14%) inpatient infections were classified as definite/probable nosocomial, 615(77%) as community-acquired and 79(10%) as indeterminate. There was strong epidemiological evidence to support definite/probable cases as nosocomial. Many indeterminate cases were likely infected in hospital: 53/79(67%) had a prior-negative PCR and 75(95%) contact with a potential source. 89/615(11% of all 803 patients) with apparent community-onset had a recent hospital exposure. Within 764 samples sequenced 607 genomic clusters were identified (>1 SNP distinct). Only 43/607(7%) clusters contained evidence of onward transmission (subsequent cases within ≤ 1 SNP). 20/21 epidemiologically-identified outbreaks contained multiple genomic introductions. Most (80%) nosocomial acquisition occurred in rapid super-spreading events in settings with a mix of COVID-19 and non-COVID-19 patients.

conclusionsCurrent surveillance definitions underestimate nosocomial acquisition. Most nosocomial transmission occurs from a relatively limited number of highly infectious individuals.

Indexed as

COVID-19Cross InfectionDisease OutbreaksHospitalsHumansSARS-CoV-2EpidemiologyNosocomial infectionSARS-CoV-2Whole genome sequencing

Identifiers

PMID34332019
PMCPMC8316632
OpenAlexW3192094462

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.